Table 4.
Patient treatment-related adverse events.
| Adverse Events | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|
| Abdominal pain | 13 (25.40%) | 5 (9.80%) | 2 (3.90%) | 0 (0.00%) |
| Anorexia | 27 (52.90%) | 7 (13.70%) | 6 (11.80%) | 1 (1.90%) |
| Vomiting | 17 (33.30%) | 3 (5.90%) | 5 (9.80%) | 1 (1.90%) |
| Fever | 6 (11.80%) | 1 (1.90%) | 1 (1.90%) | 0 (0.00%) |
| Diarrhea | 9 (17.60%) | 3 (5.90%) | 3 (5.90%) | 0 (0.00%) |
| Leukopenia | 14 (27.50%) | 6 (11.80%) | 5 (9.80%) | 0 (0.00%) |
| Thrombocytopenia | 22 (43.10%) | 12 (23.50%) | 5 (9.80%) | 1 (1.90%) |
| Elevated transaminases | 28 (54.90%) | 6 (11.80%) | 5 (9.80%) | 1 (1.90%) |
| Elevated bilirubin | 16 (31.40%) | 5 (9.80%) | 2 (3.90%) | 0 (0.00%) |
| Renal insufficiency | 5 (9.80%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Hypoproteinemia | 9 (17.60%) | 6 (11.80%) | 3 (5.90%) | 0 (0.00%) |
| Cholangitis | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Liver failure | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Catheter dislodgement | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Catheter thrombosis | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Hypertension | 12 (23.50%) | 5 (9.80%) | 2 (3.90%) | 0 (0.00%) |
| Gastrointestinal bleeding | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (1.90%) |